Enanta Pharmaceuticals, Inc. (ENTA)
11.88
-0.12
(-1.00%)
USD |
NASDAQ |
Sep 25, 16:00
11.88
0.00 (0.00%)
After-Hours: 19:59
Enanta Pharmaceuticals Net Income (TTM) : -63.23M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -63.23M |
| March 31, 2026 | -61.98M |
| December 31, 2025 | -71.54M |
| September 30, 2025 | -81.89M |
| June 30, 2025 | -92.01M |
| March 31, 2025 | -96.42M |
| December 31, 2024 | -104.93M |
| September 30, 2024 | -116.04M |
| June 30, 2024 | -115.33M |
| March 31, 2024 | -131.74M |
| December 31, 2023 | -138.24M |
| September 30, 2023 | -133.82M |
| June 30, 2023 | -132.06M |
| March 31, 2023 | -124.69M |
| December 31, 2022 | -120.63M |
| September 30, 2022 | -121.76M |
| June 30, 2022 | -120.01M |
| March 31, 2022 | -112.33M |
| December 31, 2021 | -100.78M |
| September 30, 2021 | -79.00M |
| June 30, 2021 | -83.74M |
| March 31, 2021 | -73.98M |
| December 31, 2020 | -57.94M |
| September 30, 2020 | -36.17M |
| June 30, 2020 | 2.364M |
| Date | Value |
|---|---|
| March 31, 2020 | 23.66M |
| December 31, 2019 | 33.82M |
| September 30, 2019 | 46.38M |
| June 30, 2019 | 64.61M |
| March 31, 2019 | 77.86M |
| December 31, 2018 | 86.27M |
| September 30, 2018 | 71.96M |
| June 30, 2018 | 81.04M |
| March 31, 2018 | 52.33M |
| December 31, 2017 | 34.38M |
| September 30, 2017 | 17.71M |
| June 30, 2017 | -20.60M |
| March 31, 2017 | -13.25M |
| December 31, 2016 | -9.503M |
| September 30, 2016 | 21.67M |
| June 30, 2016 | 29.28M |
| March 31, 2016 | 32.77M |
| December 31, 2015 | 63.17M |
| September 30, 2015 | 78.99M |
| June 30, 2015 | 68.14M |
| March 31, 2015 | 115.77M |
| December 31, 2014 | 81.82M |
| September 30, 2014 | 34.44M |
| June 30, 2014 | 35.04M |
| March 31, 2014 | -19.15M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Perspective Therapeutics, Inc. | -116.63M |
| Coherus Oncology, Inc. | -161.15M |
| BridgeBio Pharma, Inc. | -702.02M |
| RenovoRx, Inc. | -12.28M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |